Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-15 Sale | 2023-06-20 5:23 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 2,296 | $28.02 | $64,343 | 104,905 (Direct) | View |
| 2023-06-02 Sale | 2023-06-06 7:41 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 7,500 | $24.82 | $186,136 | 221,975 (Direct) | View |
| 2023-03-09 Sale | 2023-03-10 4:05 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 29,971 | $29.07 | $871,257 | 0 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 6:04 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 6,843 | $35.66 | $244,021 | 59,753 (Direct) | View |
| 2022-12-20 Sale | 2022-12-22 4:42 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,926 | $29.15 | $493,398 | 105,768 (Direct) | View |
| 2022-12-15 Sale | 2022-12-19 7:22 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,597 | $28.37 | $45,311 | 124,591 (Direct) | View |
| 2022-12-12 Sale | 2022-12-14 8:56 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,256 | $28.12 | $457,077 | 142,144 (Direct) | View |
| 2022-11-15 Sale | 2022-11-16 6:45 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 8,125 | $22.05 | $179,156 | 21,875 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-09-12 9:20 pm | N/A 2033-12-14 | Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer | 0 | $0 | 388,502 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 5:23 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 2,296 | $23.03 | 104,905 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 5:23 pm | N/A 2031-01-18 | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 2,297 | $0 | 104,905 (Direct) | View |
| 2023-06-05 Exercise | 2023-06-06 7:41 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 5,625 | $18.51 | 221,975 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-06 7:41 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 1,875 | $14 | 221,975 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-06 7:41 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara Chief Legal Officer | 7,500 | $0 | 221,975 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-10 4:47 pm | N/A 2033-02-08 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 108,000 | $0 | 108,000 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 6:04 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 4,971 | $23.03 | 59,753 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 6:04 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,872 | $14 | 59,753 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 6:04 pm | N/A 2031-01-18 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 6,843 | $0 | 59,753 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 4:42 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,926 | $23.03 | 105,768 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 4:42 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,926 | $0 | 105,768 (Direct) | View |
| 2022-12-15 Exercise | 2022-12-19 7:22 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,597 | $23.03 | 124,591 (Direct) | View |
| 2022-12-15 Exercise | 2022-12-19 7:22 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,597 | $0 | 124,591 (Direct) | View |
| 2022-12-12 Exercise | 2022-12-14 8:56 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,256 | $23.03 | 142,144 (Direct) | View |
| 2022-12-12 Exercise | 2022-12-14 8:56 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,256 | $0 | 142,144 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-16 6:45 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 8,125 | $14 | 21,875 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-16 6:45 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 8,125 | $0 | 21,875 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-03 6:12 pm | N/A 2032-02-02 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 90,000 | $0 | 90,000 (Direct) | View |
Ownership | 2021-10-04 6:38 pm | N/A 2031-01-18 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 0 | $0 | 109,500 (Direct) | View |